Shed syndecan‐1 promotes the growth of myeloma in vivo, a process enhanced by heparanase through a dual action involving induction of syndecan‐1 synthesis and enzymatic removal of HS‐GAGs from the protein core (Figure 2A) [11]. This evidence concerns the gene HPSE and plasma cell myeloma.